Friday, March 7, 2025
spot_img

Clarus Reports Fourth Quarter and Full Year 2024 Results

Fourth Quarter Sales of $71.4 million, Adjusted EBITDA of $4.4 million, and Free Cash Flow of $14.4 million

Completed the Acquisition of RockyMounts, Expanding Adventure’s Bike-Rack Product Capabilities Globally

SALT LAKE CITY, March 06, 2025 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, reported financial results for the fourth quarter and full year ended December 31, 2024.

Fourth Quarter 2024 Financial Summary vs. Same YearAgo Quarter (adjusted to reflect the reclassification of the Precision Sport segment as discontinued operations)

  • Sales of $71.4 million compared to $76.5 million.
  • Gross margin was 33.4% compared to 28.9%; adjusted gross margin of 38.0% compared to 34.7%.
  • Net loss, which includes the impact of discontinued operations, of $65.5 million, or $(1.71) per diluted share1, compared to net loss of $8.4 million, or $(0.22) per diluted share.
  • Loss from continuing operations of $73.3 million, or $(1.92) per diluted share, compared to loss from continuing operations of $7.2 million, or $(0.19) per diluted share.
  • Adjusted loss from continuing operations of $3.2 million, or $(0.08) per diluted share, compared to adjusted income from continuing operations of $1.6 million, or $0.04 per diluted share.
  • Adjusted EBITDA from continuing operations of $4.4 million with an adjusted EBITDA margin of 6.1% compared to $1.6 million with an adjusted EBITDA margin of 2.1%.

2024 Financial Summary vs. 2023 (adjusted to reflect the reclassification of the Precision Sport segment as discontinued operations)

  • Sales of $264.3 million compared to $286.0 million.
  • Gross margin was 35.0% compared to 34.1%; adjusted gross margin was 37.5% compared to 35.6%.
  • Net loss, which includes the impact of discontinued operations, of $52.3 million, or $(1.37) per diluted share2, compared to net loss of $10.1 million, or $(0.27) per diluted share.
  • Loss from continuing operations of $88.4 million, or $(2.31) per diluted share, compared to loss from continuing operations of $15.8 million, or $(0.42) per diluted share.
  • Adjusted loss from continuing operations of $2.6 million, or $(0.07) per diluted share, compared to adjusted income from continuing operations of $3.8 million, or $0.10 per diluted share.
  • Adjusted EBITDA of $6.9 million with an adjusted EBITDA margin of 2.6% compared to $7.3 million with an adjusted EBITDA margin of 2.6%.

1 Includes $44.8 million impairment of goodwill and indefinite-lived intangible assets as well as a $21.0 million tax expense for the establishment of a valuation allowance associated with deferred tax assets.

2 Includes gain on sale Precision Sport segment of $40.6 million as well as $44.8 million impairment of goodwill and indefinite-lived intangible assets as well as a $21.0 million tax expense for the establishment of a valuation allowance associated with deferred tax assets.

Management Commentary
“During 2024 we remained focused on executing against our strategic roadmap and positioning Clarus for profitable growth over the long term,” said Warren Kanders, Clarus’ Executive Chairman. “Despite significant market headwinds, we took important steps during the year to simplify and strengthen the core at the Outdoor segment, while investing in new R&D and product development initiatives to scale the Adventure segment. At Outdoor, we made steady progress building a smaller, more profitable business in 2024. Primarily as a result of our product simplification and SKU rationalization initiatives, Outdoor adjusted gross margin improved to 36.9% in Q4 compared to 32.8% in the year ago quarter. In the Adventure segment, we anticipated this past year would require significant investment, and despite a difficult 2024, we are committed to maintaining these fixed investments to scale the business globally outside the home region of Australia.”

Mr. Kanders added, “We enter 2025 encouraged by the strides our teams have made to advance our turnaround and excited about the potential to unlock new growth opportunities going forward. Following multiple quarters of incremental progress at Outdoor, we believe our success simplifying the business, rightsizing inventory and reshaping the organization positions Black Diamond for a return to growth as the market stabilizes. While initiatives to accelerate our Adventure brands’ traction in global markets will continue to take time, we have enhanced product development and the commercialization processes and plan to launch compelling new products throughout the coming year. With the recent acquisition of RockyMounts, we now have a comprehensive portfolio of roof and hitch-mounted bike racks solutions to reach a broader addressable market of customers in North America, Australia and New Zealand.”

Fourth Quarter 2024 Financial Results
On a consolidated basis, sales in the fourth quarter were $71.4 million compared to $76.5 million in the same year‐ago quarter. This decrease was primarily driven by isolated challenges with two large accounts in our OEM and Australian wholesale channels in our Adventure segment. This decline was partly offset by growth in the North American wholesale and international distribution channels at the Outdoor segment.

Sales in the Outdoor segment were $51.1 million, compared to $50.1 million in the year-ago quarter. Sales in the Adventure segment decreased 22.9% to $20.3 million, compared to $26.4 million in the year-ago quarter.

Gross margin in the fourth quarter was 33.4% compared to 28.9% in the year‐ago quarter. The increase in gross margin was primarily due to lower PFAS inventory reserves related movements compared to the prior year at the Outdoor segment. This was further improved by favorable product mix due to continued product simplification and SKU rationalization efforts at the Outdoor segment, as well as a favorable channel mix at the Adventure segment due to lower OEM sales. This was partially offset by a $2.3 million increase in the inventory reserve at the Adventure segment to address slow-moving and obsolete inventory. Adjusted gross margin reflecting the PFAS related, other one-time inventory reserve movements, and inventory fair value adjustments as a result of purchase accounting was 38.0% for the quarter compared to 34.7% in the year-ago quarter.

Selling, general and administrative expenses in the fourth quarter were $27.8 million compared to $30.0 million in the same year‐ago quarter. The decrease was primarily a result of lower marketing, research and development, and retail expenses due to store closures at the Outdoor segment as well as lower corporate costs. These reductions were partially offset by investments in marketing, research and development, and e-commerce initiatives, primarily at Rhino-Rack USA in the Adventure segment.

During the fourth quarter, the Company incurred non-cash expense for goodwill and indefinite-lived assets impairments of $44.8 million as well as an increase in tax expense of $21.0 million for a valuation allowance to fully reserve all deferred tax assets associated with U.S. federal income taxes.

The loss from continuing operations in the fourth quarter of 2024 was $73.3 million, or $(1.92) per diluted share, compared to loss from continuing operations of $7.2 million, or $(0.19) per diluted share in the year-ago quarter. Loss from continuing operations in the fourth quarter included a non-cash impairment of goodwill and indefinite-lived intangible assets charge of $44.8 million in the Adventure segment due to the decline in the Company’s stock price and lower sales and profitability in the segment compared to expectations. The loss also includes $8.7 million of cost and charges associated with amortization of intangibles, restructuring charges, transactions costs, inventory fair value adjustment from purchase accounting, PFAS and other inventory reserves, legal costs and regulatory matter expenses, and stock-based compensation.

Adjusted loss from continuing operations in the fourth quarter of 2024 was $3.2 million, or $(0.08) per diluted share, compared to adjusted income from continuing operations of $1.6 million, or $0.04 per diluted share, in the year-ago quarter. Adjusted loss from continuing operations excludes amortization of intangibles, impairment of goodwill and indefinite-lived intangible assets, restructuring charges, transactions costs, inventory fair value adjustment from purchase accounting, PFAS and other inventory reserves, legal costs and regulatory matter expenses, and stock-based compensation.

Adjusted EBITDA from continuing operations in the fourth quarter was $4.4 million, or an adjusted EBITDA margin of 6.1%, compared to adjusted EBITDA from continuing operations of $1.6 million, or an adjusted EBITDA margin of 2.1%, in the same year‐ago quarter.

Net cash provided in operating activities for the three months ended December 31, 2024, was $16.6 million compared to net cash provided by operating activities of $14.5 million in the prior year quarter. Capital expenditures in the fourth quarter of 2024 were $2.2 million compared to $1.2 million in the prior year quarter. Free cash flow for the fourth quarter of 2024 was $14.4 million compared to $13.3 million in the prior year quarter.

Liquidity at December 31, 2024 vs. December 31, 2023

  • Cash and cash equivalents totaled $45.4 million compared to $11.3 million.
  • Total debt of $1.9 million (related to the RockyMounts acquisition) compared to $119.8 million.

Full Year 2024 Financial Results
Sales in 2024 decreased 7.6% to $264.3 million compared to $286.0 million in 2023. The decrease in sales was primarily driven by continued softness across all selling channels in Outdoor, combined with the effects of the Company’s product line simplification strategy, as well as lower Adventure segment sales. The Adventure decline resulted from less OEM channel demand and challenging wholesale markets globally, partially offset by the benefit from the TRED Outdoors acquisition.

From a segment perspective, Outdoor sales were down 10.0% to $183.6 million and Adventure sales were down 1.5% to $80.7 million, or $81.3 million on a constant currency basis, compared to 2023.

Gross margin in 2024 was 35.0% compared to 34.1% in 2023 primarily due to favorable product mix at the Outdoor segment as a result of product simplification and SKU rationalization efforts, combined with favorable Adventure segment channel mix due to lower OEM sales. This was partially offset by a $2.3 million inventory reserve expenses at the Adventure segment. Adjusted gross margin reflecting the PFAS related inventory reserve, Adventure inventory reserve, and inventory fair value purchase accounting was 37.5% for the year compared to 35.6% in the prior year.

Selling, general and administrative expenses in 2024 were $111.9 million compared to $114.6 million in 2023. The decrease was primarily due to lower retail expenses due to store closures and lower marketing and research and development expenses at the Outdoor segment. These decreases were partially offset by investments in global marketing, operational improvements, and e-commerce initiatives to accelerate growth at the Adventure segment and incremental SG&A from the TRED Outdoors acquisition.

Loss from continuing operations in 2024 was $88.4 million, or $(2.31) per diluted share, compared to net loss of $15.8 million, or $(0.42) per diluted share, in the prior year. Loss from continuing operations for 2024 included a non-cash impairment of goodwill and indefinite-lived intangible assets charge of $44.8 million in the Adventure segment due to the decline in the Company’s stock price and lower sales and profitability in the segment compared to expectations. The loss also includes $28.4 million of cost and charges associated with amortization of intangibles, restructuring charges, transactions costs, contingent consideration benefit, inventory fair value of purchase accounting, PFAS and other inventory reserves, legal costs and regulatory matter expenses, and stock-based compensation.

Adjusted loss from continuing operations in 2024 was $2.6 million, or $(0.07) per diluted share, compared to adjusted income from continuing operations of $3.8 million, or $0.10 per diluted share in the year-ago quarter. Adjusted loss from continuing operations excludes amortization of intangibles, impairment of goodwill and indefinite-lived intangible assets, restructuring expenses, transactions costs, contingent consideration benefit, inventory fair value of purchase accounting, PFAS and other inventory reserves, legal costs and regulatory matter expenses, and stock-based compensation.

Adjusted EBITDA in 2024 was $6.9 million, or an adjusted EBITDA margin of 2.6%, compared to $7.3 million, or an adjusted EBITDA margin of 2.6%, in 2023.

Net cash used in operating activities for the year ended December 31, 2024, was $7.3 million compared to net cash provided by operating activities of $31.9 million in 2023. Capital expenditures in 2024 were $6.7 million compared to $5.7 million in the prior year. Free cash flow for the year ended December 31, 2024, was $(14.0) million compared to $26.2 million in the same year‐ago period.

Acquisition of RockyMounts
In December, Rhino-Rack USA completed the acquisition of certain assets and liabilities constituting the RockyMounts business, a Colorado-based brand specializing in bicycle transport products, that we expect to deepen Rhino-Rack’s product expertise in a key growth vertical. For over 30 years, RockyMounts has designed innovative roof and hitch rack solutions, attracting a dedicated following of customers thanks to the products’ distinct style and exceptional durability. Founded in Boulder, Colorado in 1993, RockyMounts is known for making well designed and dependable premium bicycle racks and other accessories compatible with vehicles of all sizes, including SUVs, vans and trucks. Its award-winning products can be found in local and national retailers across North America.

2025 Outlook
The Company expects fiscal year 2025 sales to range between $250 million to $260 million and adjusted EBITDA of approximately $14 million to $16 million, or an adjusted EBITDA margin of 5.9% at the mid-point of revenue and adjusted EBITDA. In addition, capital expenditures are expected to range between $4 million to $5 million and free cash flow is expected to range between $8 million to $10 million for the full year 2025. Clarus has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not Adjusted EBITDA and/or Adjusted EBITDA Margin. Therefore, we do not provide a reconciliation of Adjusted EBITDA and/or Adjusted EBITDA Margin guidance to net income guidance.

Net Operating Loss (NOL) and Deferred Tax Asset Valuation Allowance
The Company has historically had net operating loss carryforwards (“NOLs”) for U.S. federal income tax purposes. During 2024 the remaining NOLs have been utilized. Additionally, during the fourth quarter of 2024 the Company established a full valuation allowance through a charge to income tax expense for $21.0 million.

Conference Call
The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its fourth quarter 2024 results.

Date: Thursday, March 6, 2025
Time: 5:00 pm ET
Registration Link: https://register.vevent.com/register/BI193a68bc624f4d3cb299c6cede17b335

To access the call by phone, please register via the live call registration link above and you will be provided with dial-in instructions and details. The conference call will be broadcast live and available for replay here and on the Company’s website at www.claruscorp.com.

About Clarus Corporation
 Headquartered in Salt Lake City, Utah, Clarus Corporation is a global leader in the design and development of best-in-class equipment and lifestyle products for outdoor enthusiasts. Driven by our rich history of engineering and innovation, our objective is to provide safe, simple, effective and beautiful products so that our customers can maximize their outdoor pursuits and adventures. Each of our brands has a long history of continuous product innovation for core and everyday users alike. The Company’s products are principally sold globally under the Black Diamond®, Rhino-Rack®, MAXTRAX®, and TRED Outdoors® brand names through outdoor specialty and online retailers, our own websites, distributors, and original equipment manufacturers.

Use of Non‐GAAP Measures
The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). This press release contains the non-GAAP measures: (i) adjusted gross margin and adjusted gross profit, (ii) adjusted (loss) income from continuing operations and related earnings (loss) per diluted share, (iii) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), EBITDA margin, adjusted EBITDA, and adjusted EBITDA margin, and (iv) free cash flow (defined as net cash provided by operating activities less capital expenditures). The Company believes that the presentation of certain non-GAAP measures, i.e.: (i) adjusted gross margin and adjusted gross profit, (ii) adjusted (loss) income from continuing operations and related earnings (loss) per diluted share, (iii) EBITDA, EBITDA margin, adjusted EBITDA and adjusted EBITDA margin, and (iv) free cash flow, provide useful information for the understanding of its ongoing operations and enables investors to focus on period-over-period operating performance, and thereby enhances the user’s overall understanding of the Company’s current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measures Adjusted EBITDA and/or Adjusted EBITDA Margin for the fiscal year 2025 to net income for the fiscal year 2025, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA and/or Adjusted EBITDA Margin. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company’s reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

Forward-Looking Statements
Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including under the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company’s Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

Company Contact:
Michael J. Yates
Chief Financial Officer
[email protected]

Investor Relations:
The IGB Group
Leon Berman / Matt Berkowitz
Tel 1-212-477-8438 / 1-212-227-7098
[email protected] / [email protected]

CLARUS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except per share amounts)
       
  December 31, 2024   December 31, 2023
Assets          
Current assets          
Cash $ 45,359     $ 11,324  
Accounts receivable, net   43,678       53,971  
Inventories   82,278       91,409  
Prepaid and other current assets   5,555       4,865  
Income tax receivable   910       892  
Assets held for sale         137,284  
Total current assets   177,780       299,745  
           
Property and equipment, net   17,606       16,587  
Other intangible assets, net   31,516       41,466  
Indefinite-lived intangible assets   46,750       58,527  
Goodwill   3,804       39,320  
Deferred income taxes   36       22,869  
Other long-term assets   16,602       16,824  
Total assets $ 294,094     $ 495,338  
           
Liabilities and Stockholders’ Equity          
Current liabilities          
Accounts payable $ 11,873     $ 20,015  
Accrued liabilities   22,276       24,580  
Income tax payable         805  
Current portion of long-term debt   1,888       119,790  
Liabilities held for sale         5,744  
Total current liabilities   36,037       170,934  
           
Deferred income taxes   12,210       18,124  
Other long-term liabilities   12,754       14,160  
Total liabilities   61,001       203,218  
           
Stockholders’ Equity          
Preferred stock, $0.0001 par value per share; 5,000 shares authorized; none issued          
Common stock, $0.0001 par value per share; 100,000 shares authorized; 43,004 and 42,761 issued and 38,362 and 38,149 outstanding, respectively   4       4  
Additional paid in capital   697,592       691,198  
Accumulated deficit   (406,857 )     (350,739 )
Treasury stock, at cost   (33,114 )     (32,929 )
Accumulated other comprehensive loss   (24,532 )     (15,414 )
Total stockholders’ equity   233,093       292,120  
Total liabilities and stockholders’ equity $ 294,094     $ 495,338  
CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF LOSS
(Unaudited)
(In thousands, except per share amounts)
           
  Three Months Ended
  December 31, 2024   December 31, 2023
           
Sales          
Domestic sales $ 30,162     $ 31,840  
International sales   41,243       44,663  
Total sales   71,405       76,503  
           
Cost of goods sold   47,540       54,361  
Gross profit   23,865       22,142  
           
Operating expenses          
Selling, general and administrative   27,772       29,963  
Restructuring charges   939       1,411  
Transaction costs   408       134  
Legal costs and regulatory matter expenses   47       702  
Impairment of goodwill   36,264        
Impairment of indefinite-lived intangible assets   8,545        
           
Total operating expenses   73,975       32,210  
           
Operating loss   (50,110 )     (10,068 )
           
Other income (expense)          
Interest income, net   269       35  
Other, net   (2,342 )     1,104  
           
Total other (expense) income, net   (2,073 )     1,139  
           
Loss before income tax   (52,183 )     (8,929 )
Income tax expense (benefit)   21,142       (1,700 )
Loss from continuing operations   (73,325 )     (7,229 )
           
Discontinued operations, net of tax   7,804       (1,160 )
           
Net loss $ (65,521 )   $ (8,389 )
           
Loss from continuing operations per share:          
Basic $ (1.92 )   $ (0.19 )
Diluted   (1.92 )     (0.19 )
           
Net loss per share:          
Basic $ (1.71 )   $ (0.22 )
Diluted   (1.71 )     (0.22 )
           
Weighted average shares outstanding:          
Basic   38,262       38,312  
Diluted   38,262       38,312  
CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF LOSS
(Unaudited)
(In thousands, except per share amounts)
           
  Twelve Months Ended
  December 31, 2024   December 31, 2023
           
Sales          
Domestic sales $ 105,745     $ 112,385  
International sales   158,570       173,635  
Total sales   264,315       286,020  
           
Cost of goods sold   171,696       188,509  
Gross profit   92,619       97,511  
           
Operating expenses          
Selling, general and administrative   111,948       114,603  
Restructuring charges   1,948       3,223  
Transaction costs   576       593  
Contingent consideration benefit   (125 )     (1,565 )
Legal costs and regulatory matter expenses   3,842       1,764  
Impairment of goodwill   36,264        
Impairment of indefinite-lived intangible assets   8,545        
           
Total operating expenses   162,998       118,618  
           
Operating loss   (70,379 )     (21,107 )
           
Other (expense) income          
Interest income, net   1,467       67  
Other, net   (1,673 )     961  
           
Total other (expense) income, net   (206 )     1,028  
           
Loss before income tax   (70,585 )     (20,079 )
Income tax expense (benefit)   17,852       (4,291 )
Loss from continuing operations   (88,437 )     (15,788 )
           
Discontinued operations, net of tax   36,150       5,642  
           
Net loss $ (52,287 )   $ (10,146 )
           
Loss from continuing operations per share:          
Basic $ (2.31 )   $ (0.42 )
Diluted   (2.31 )     (0.42 )
           
Net loss per share:          
Basic $ (1.37 )   $ (0.27 )
Diluted   (1.37 )     (0.27 )
           
Weighted average shares outstanding:          
Basic   38,305       37,485  
Diluted   38,305       37,485  
CLARUS CORPORATION
RECONCILIATION FROM GROSS PROFIT TO ADJUSTED GROSS PROFIT
AND ADJUSTED GROSS MARGIN
               
THREE MONTHS ENDED
     
  December 31, 2024       December 31, 2023
               
Sales $ 71,405     Sales   $ 76,503  
               
Gross profit as reported $ 23,865     Gross profit as reported   $ 22,142  
Plus impact of inventory fair value adjustment   61     Plus impact of inventory fair value adjustment     64  
Plus impact of PFAS and other inventory reserves   3,179     Plus impact of PFAS and other inventory reserves     4,370  
Adjusted gross profit $ 27,105     Adjusted gross profit   $ 26,576  
               
Gross margin as reported   33.4 %   Gross margin as reported     28.9 %
               
Adjusted gross margin   38.0 %   Adjusted gross margin     34.7 %
               
TWELVE MONTHS ENDED
               
  December 31, 2024       December 31, 2023
               
Sales $ 264,315     Sales   $ 286,020  
               
Gross profit as reported $ 92,619     Gross profit as reported   $ 97,511  
Plus impact of inventory fair value adjustment   61     Plus impact of inventory fair value adjustment     64  
Plus impact of PFAS and other inventory reserves   6,502     Plus impact of PFAS and other inventory reserves     4,370  
Adjusted gross profit $ 99,182     Adjusted gross profit   $ 101,945  
               
Gross margin as reported   35.0 %   Gross margin as reported     34.1 %
               
Adjusted gross margin   37.5 %   Adjusted gross margin     35.6 %

CLARUS CORPORATION
RECONCILIATION FROM LOSS FROM CONTINUING OPERATIONS TO ADJUSTED (LOSS) INCOME FROM CONTINUING OPERATIONS AND RELATED EARNINGS PER DILUTED SHARE
(In thousands, except per share amounts)
                                           
  Three Months Ended December 31, 2024
  Total   Gross   Operating   Income tax   Tax   (Loss) income from   Diluted
  sales   profit   expenses   (benefit) expense   rate   continuing operations   EPS(1)
                                           
As reported $ 71,405     $ 23,865     $ 73,975     $ 21,142       40.5 %   $ (73,325 )   $ (1.92 )
                                           
Amortization of intangibles               (2,468 )     1,240           1,228        
Impairment of goodwill               (36,264 )               36,264        
Impairment of indefinite-lived intangible assets               (8,545 )     2,564           5,981        
Restructuring charges               (939 )     251           688        
Transaction costs               (408 )     87           321        
Inventory fair value of purchase accounting         61             13           48        
PFAS and other inventory reserves         3,179             766           2,413        
Legal costs and regulatory matter expenses               (47 )     23           24        
Stock-based compensation               (1,570 )     (588 )         2,158        
Valuation allowance                     (21,038 )         21,038        
                                           
As adjusted $ 71,405     $ 27,105     $ 23,734     $ 4,460       343.6 %   $ (3,162 )   $ (0.08 )
                                           
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share and adjusted loss from continuing operations per share are both calculated based on 38,262 basic and diluted weighted average shares of common stock.
                                           
  Three Months Ended December 31, 2023
  Total   Gross   Operating   Income tax   Tax   (Loss) income from   Diluted
  sales   profit   expenses   (benefit) expense   rate   continuing operations   EPS(1)
                                           
As reported $ 76,503     $ 22,142     $ 32,210     $ (1,700 )     (19.0 )%   $ (7,229 )   $ (0.19 )
                                           
Amortization of intangibles               (2,680 )     536           2,144        
Restructuring charges               (1,411 )     282           1,129        
Transaction costs               (134 )     27           107        
Inventory fair value of purchase accounting         64             13           51        
PFAS and other inventory reserves         4,370             575           3,795        
Legal costs and regulatory matter expenses               (702 )     35           667        
Stock-based compensation               (1,218 )     244           974        
                                           
As adjusted $ 76,503     $ 26,576     $ 26,065     $ 12       0.7 %   $ 1,638     $ 0.04  
                                           
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share is calculated based on 38,312 basic and diluted weighted average shares of common stock. Adjusted income from continuing operations per share is calculated based on 38,479 diluted shares of common stock.
                                           

CLARUS CORPORATION
RECONCILIATION FROM LOSS FROM CONTINUING OPERATIONS TO ADJUSTED (LOSS) INCOME FROM CONTINUING OPERATIONS AND RELATED EARNINGS PER DILUTED SHARE
(In thousands, except per share amounts)
                                           
  Twelve Months Ended December 31, 2024
  Total   Gross   Operating   Income tax   Tax   (Loss) income from   Diluted
  sales   profit   expenses   (benefit) expense   rate   continuing operations   EPS(1)
                                           
As reported $ 264,315     $ 92,619     $ 162,998     $ 17,852       25.3 %   $ (88,437 )   $ (2.31 )
                                           
Amortization of intangibles               (9,784 )     2,751           7,033        
Impairment of goodwill               (36,264 )               36,264        
Impairment of indefinite-lived intangible assets               (8,545 )     2,564           5,981        
Restructuring charges               (1,948 )     459           1,489        
Transaction costs               (576 )     122           454        
Contingent consideration benefit               125       (26 )         (99 )      
Inventory fair value of purchase accounting         61             13           48        
PFAS and other inventory reserves         6,502             1,453           5,049        
Legal costs and regulatory matter expenses               (3,842 )     807           3,035        
Stock-based compensation               (5,823 )     291           5,532        
Valuation allowance                     (21,038 )         21,038        
                                           
As adjusted $ 264,315     $ 99,182     $ 96,341     $ 5,248       199.2 %   $ (2,613 )   $ (0.07 )
                                           
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share and adjusted loss from continuing operations per share are both calculated based on 38,305 basic and diluted weighted average shares of common stock.
                                           
  Twelve Months Ended December 31, 2023
  Total   Gross   Operating   Income tax   Tax   (Loss) income from   Diluted
  sales   profit   expenses   (benefit) expense   rate   continuing operations   EPS(1)
                                           
As reported $ 286,020     $ 97,511     $ 118,618     $ (4,291 )     (21.4 )%   $ (15,788 )   $ (0.42 )
                                           
Amortization of intangibles               (10,715 )     2,293           8,422        
Restructuring charges               (3,223 )     690           2,533        
Transaction costs               (593 )     127           466        
Contingent consideration benefit               1,565       (335 )         (1,230 )      
Inventory fair value of purchase accounting         64             14           50        
PFAS and other inventory reserves         4,370             575           3,795        
Legal costs and regulatory matter expenses               (1,764 )     261           1,503        
Stock-based compensation               (5,141 )     1,100           4,041        
                                           
As adjusted $ 286,020     $ 101,945     $ 98,747     $ 434       10.3 %   $ 3,792     $ 0.10  
                                           
(1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share is calculated based on 37,485 basic and diluted weighted average shares of common stock. Adjusted income from continuing operations per share is calculated based on 38,088 diluted shares of common stock.

 

CLARUS CORPORATION
RECONCILIATION FROM OPERATING (LOSS) INCOME TO EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA), EBITDA MARGIN, ADJUSTED EBITDA, AND ADJUSTED EBITDA MARGIN
(In thousands)
 
  Three Months Ended December 31, 2024   Three Months Ended December 31, 2023
  Outdoor
Segment
  Adventure
Segment
    Corporate
Costs
    Total     Outdoor
Segment
    Adventure
Segment
  Corporate
Costs
    Total  
                                                               
Operating (loss) income $ 1,897     $ (48,582 )   $ (3,425 )   $ (50,110 )   $ (7,002 )   $ 1,051     $ (4,117 )   $ (10,068 )
Depreciation   614       369             983       715       371             1,086  
Amortization of intangibles   285       2,183             2,468       285       2,395             2,680  
                                                               
EBITDA   2,796       (46,030 )     (3,425 )     (46,659 )     (6,002 )     3,817       (4,117 )     (6,302 )
                                                               
Restructuring charges   789       150             939       1,372       39             1,411  
Transaction costs   65       307       36       408             1       133       134  
Legal costs and regulatory matter expenses   10             37       47       260             442       702  
Impairment of goodwill         36,264             36,264                          
Impairment of indefinite-lived intangible assets         8,545             8,545                          
Stock-based compensation               1,570       1,570                   1,218       1,218  
Inventory fair value of purchase accounting         61             61             64             64  
PFAS and other inventory reserves   869       2,310             3,179       4,370                   4,370  
                                                               
Adjusted EBITDA $ 4,529     $ 1,607     $ (1,782 )   $ 4,354     $     $ 3,921     $ (2,324 )   $ 1,597  
                                                               
Sales $ 51,072     $ 20,333     $     $ 71,405       50,135       26,368             76,503  
                                                               
EBITDA margin   5.5 %     (226.4 )%             (65.3 )%     (12.0 )%     14.5 %             (8.2 )%
Adjusted EBITDA margin   8.9 %     7.9 %             6.1 %     %     14.9 %             2.1 %

 

CLARUS CORPORATION
RECONCILIATION FROM OPERATING (LOSS) INCOME TO EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA), EBITDA MARGIN, ADJUSTED EBITDA, AND ADJUSTED EBITDA MARGIN
(In thousands)
                                               
  Twelve Months Ended December 31, 2024   Twelve Months Ended December 31, 2023
  Outdoor
Segment
  Adventure
Segment
  Corporate
Costs
  Total   Outdoor
Segment
  Adventure
Segment
  Corporate
Costs
  Total
                                               
Operating (loss) income $ (999 )   $ (53,126 )   $ (16,254 )   $ (70,379 )   $ (5,155 )   $ 911     $ (16,863 )   $ (21,107 )
Depreciation   2,588       1,446             4,034       2,848       1,302             4,150  
Amortization of intangibles   1,142       8,642             9,784       1,057       9,658             10,715  
                                               
EBITDA   2,731       (43,038 )     (16,254 )     (56,561 )     (1,250 )     11,871       (16,863 )     (6,242 )
                                               
Restructuring charges   1,349       599             1,948       2,754       306       163       3,223  
Transaction costs   65       396       115       576             30       563       593  
Contingent consideration benefit         (125 )           (125 )           (1,565 )           (1,565 )
Legal costs and regulatory matter expenses   3,088             754       3,842       476             1,288       1,764  
Impairment of goodwill         36,264             36,264                          
Impairment of indefinite-lived intangible assets         8,545             8,545                          
Stock-based compensation               5,823       5,823                   5,141       5,141  
Inventory fair value of purchase accounting         61             61             64             64  
PFAS and other inventory reserves   4,192       2,310             6,502       4,370                   4,370  
                                               
Adjusted EBITDA $ 11,425     $ 5,012     $ (9,562 )   $ 6,875     $ 6,350     $ 10,706     $ (9,708 )   $ 7,348  
                                               
Sales $ 183,568     $ 80,747     $     $ 264,315       204,053       81,967             286,020  
                                               
EBITDA margin   1.5 %   (53.3 )%           (21.4 )%     (0.6 )%     14.5 %           (2.2 )%
Adjusted EBITDA margin   6.2 %   6.2 %           2.6 %     3.1 %     13.1 %           2.6%  

Powered by SlickText.com

Hot this week

Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results

– Enrollment completed in VIRAGE Phase 2b clinical trial...

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

Fourth Quarter Net Revenue of $74.4 million, up 0.3%...

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

- Continued progress with lead program, CX-2051 (EpCAM PROBODY®...

Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

ORKA-001, targeting IL-23p19, Phase 1 trial ongoing, with pharmacokinetic...

Topics

Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results

– Enrollment completed in VIRAGE Phase 2b clinical trial...

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

Fourth Quarter Net Revenue of $74.4 million, up 0.3%...

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

- Continued progress with lead program, CX-2051 (EpCAM PROBODY®...

Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

ORKA-001, targeting IL-23p19, Phase 1 trial ongoing, with pharmacokinetic...

Global-e to Host 2025 Investor Day

PETAH-TIKVA, Israel, March 06, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img